GENOCEA BIOSCIENCES, INC.: cashflow_investing
| Value | {"amount": -528000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-06-30 |
| Status | current |
| Entity | GENOCEA BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:23:53.831879+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fefea10f-b206-429f-ab68-52ab3974ac31
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001457612-20-000125 · Open the official SEC filing →Retrieved: 2026-08-19T14:23:53.831879+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001457612/cashflow-investing/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fefea10f-b206-429f-ab68-52ab3974ac31
History
- no predecessors — first report